Validea report rates BOSTON SCIENTIFIC CORP highest using Multi-Factor Investor model

From Nasdaq: 2025-04-25 12:07:00

Validea’s guru fundamental report for BOSTON SCIENTIFIC CORP (BSX) shows it rates highest using the Multi-Factor Investor model based on Pim van Vliet’s strategy. The strategy seeks low volatility stocks with strong momentum and high net payout yields. BSX is a large-cap growth stock in the Medical Equipment & Supplies industry, with a rating of 68% based on fundamentals and valuation. The stock meets some criteria of the strategy, but not all, as shown in the analysis table. Pim van Vliet’s research into conservative factor investing has led to this strategy, which focuses on low volatility stocks that outperform with less risk.



Read more at Nasdaq: Validea Detailed Fundamental Analysis – BSX